Skip to main content

Clinical Trials Using Dye

Review the clinical trials studying dye on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-24 of 24

A Study of Cadonilimab Combined with Chemotherapy in Treating Patients with Gastric or Gastroesophageal Junction Cancer
Status: Active
Location: 7 locations
Selective Surgical Staging versus Reflex Lymphadenectomy in Evaluating Sentinel Lymph Nodes in Non-mappers Undergoing Surgery for Endometrial Cancer
Status: Active
Location: University of Kentucky/Markey Cancer Center, Lexington, Kentucky
Magtrace for Delayed Sentinel Lymph Node Biopsy in Patients with Ductal Carcinoma In-Situ
Status: Active
Location: UF Health Cancer Institute - Gainesville, Gainesville, Florida
Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients with Sarcoma, SarcoSIGHT Trial
Status: Active
Location: City of Hope Comprehensive Cancer Center, Duarte, California
Intraoperative Imaging with Indocyanine Green for the Improvement of Functional Outcomes in Patients with Prostate Cancer
Status: Active
Location: UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California
Indocyanine Green for Imaging of Solid Tumors during Surgery Compared to Standard of Care
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Second Window Imaging using Indocyanine Green (TumorGlow-CNS) to Identify Tumor Tissue During Surgery for Nervous System Tumors
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Pembrolizumab in Combination with Chemotherapy and Image-Guided Surgery for the Treatment of Resectable Pleural Malignant Mesothelioma (MPM)
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Status: Active
Location: 45 locations
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People with Breast Cancer
Status: Active
Location: 7 locations
Immediate Lymphatic Reconstruction for the Prevention of Lymphedema in Patients with Breast Cancer, LILY Trial
Status: Active
Location: UT MD Anderson Cancer Center, Houston, Texas
Lymphovenous Bypass during Axillary Lymph Node Dissection or Inguinal Lymph Node Dissection for the Prevention of Lymphedema in Melanoma Patients
Status: Active
Location: UT MD Anderson Cancer Center, Houston, Texas
Lymphovenous Bypass Procedure before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients with Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
Status: Active
Location: UT MD Anderson Cancer Center, Houston, Texas
Study of Intra-operative Imaging in Women with Ovarian Cancer
Status: Active
Location: 9 locations
Indocyanine Green-Guided Sentinel Lymph Node Mapping for Pediatric Patients with Solid Tumors
Status: Active
Location: 3 locations
Intraoperative Tumor Margin Identification With ICG Dye Imaging
Status: Active
Location: Massachusetts General Hospital Cancer Center, Boston, Massachusetts
Fluorescent Imaging during Surgery to Identify Tissue Blood Flow and Decrease Pharyngocutaneous Fistula Rates in Laryngeal and Hypopharyngeal Cancer Patients Undergoing Total Laryngectomy
Status: Active
Location: UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
Indocyanine Green for the Imaging of Patients with Solid Tumors or Lymphoma Undergoing Surgery, ICGLOW Study
Status: Active
Location: Saint Jude Children's Research Hospital, Memphis, Tennessee
Magnetic Sentinel Lymph Node Mapping in Gastric Cancer
Status: Approved
Location: UT MD Anderson Cancer Center, Houston, Texas
Indocyanine Green to Guide Sentinel Lymph Node Mapping in Pediatric Solid Tumor Patients Undergoing Lymph Node Dissection
Status: Approved
Location: University of Rochester, Rochester, New York
Intraoperative Indocyanine Green Fluorescence Imaging for the Identification of Head and Neck Tumor Cells in Patients with a Mucosal Origin and at a High Risk of Recurrence
Status: Temporarily Closed to Accrual
Location: Medical University of South Carolina, Charleston, South Carolina
Characterizing Tumor-Draining Lymph Nodes and Other Immune Sites in Kidney Cancer
Status: Active
Location: Yale University, New Haven, Connecticut
Variations in Lymphatic Anatomy and Function of the Arm’s Alternate Lymphatic Pathway
Status: Active
Location: Beth Israel Deaconess Medical Center, Boston, Massachusetts
The Use of Indocyanine Green as a Diagnostic Adjunct for Pediatric Solid Malignancies
Status: Active
Location: See ClinicalTrials.gov